M&A

Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Tue, 04/18/23 - 10:10 pm
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
Tue, 04/18/23 - 10:24 am
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Tue, 04/18/23 - 10:15 am
Catalent
Danaher
M&A
CDMOs
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
Fierce Pharma
Mon, 04/17/23 - 10:49 pm
Pfizer
Seagen
M&A
Merck
Merck’s latest deal turns up the spotlight on immune system drugmakers
BioPharma Dive
Mon, 04/17/23 - 10:47 pm
Merck
M&A
Prometheus Biosciences
immunology
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Merck to buy inflammatory disease drugmaker Prometheus for $10.8B
BioPharma Dive
Sun, 04/16/23 - 11:31 pm
Merck
M&A
Prometheus Biosciences
IBD
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
Wed, 04/12/23 - 10:22 am
M&A
Pfizer
Seagen
Sanofi
Provention Bio
AstraZeneca
CinCor
Chiesi
Amryt
Ipsen
Albireo
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Tue, 04/11/23 - 07:16 pm
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Quince adopts 'poison pill' to fend off buyout bid as investor builds stake
Fierce Biotech
Thu, 04/6/23 - 11:32 am
Quince Therapeutics
M&A
Echo Lake Capital
poison pill
Why won’t Illumina sell Grail?
Medtech Dive
Wed, 04/5/23 - 10:06 am
Illumina
M&A
Grail
Carl Icahn
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
CNBC
Mon, 04/3/23 - 11:36 am
FTC
Illumina
Grail
competition
M&A
diagnostics
What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
Fierce Biotech
Fri, 03/31/23 - 11:53 am
M&A
GreenLight Biosciences
Egitis Therapeutics
venture capital
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
CNBC
Fri, 03/31/23 - 10:37 am
Illumina
Carl Icahn
Grail
M&A
CVS Health Completes $8 Bln Signify Health Acquisition
NASDAQ
Thu, 03/30/23 - 10:56 am
CVS Health
Signify Health
M&A
Are ICU Medical & GE HealthCare Competing to Acquire 2 Units from Medtronic?
Medical Devices and Diagnostics Industry
Wed, 03/29/23 - 04:20 pm
Medtronic
devices
Medtech
M&A
ICU Medical
GE Healthcare

Pages